Dr Reddy’s launches generic carboprost injection in US

Dr Reddy’s launches generic carboprost injection in US

The generic Carboprost Tromethamine injection used for aborting pregnancy has been released in the US market, said Dr Reddy’s Laboratories.

The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial,the company stated in a filing to BSE.

The product is a generic version of Pfizer’s Hemabate injection in the strength of 250 mcg/mL, it added.

“We are pleased to be first-to-market this product that has been designated as a Competitive Generic Therapy (CGT) by the FDA,” said Marc Kikuchi,CEO, Dr Reddy’s Laboratories North America Generics.

With a CGT designation, the company has 180-day exclusivity to market this product, he added

Straight Talk

View More